BBLG

Bone Biologics Corp Common Stock (BBLG)

Stock · NASDAQ · Health Care

$0.395as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 15, 2026

BBLG Included in After-Hours Health Care Stock Movers. Bone Biologics (BBLG) was named among twelve health‑care stocks that showed price movement in Wednesday’s after‑market session, according to Benzinga. The mention highlights recent trading activity for the company. The stock is currently near its $1.21 support level and has an RSI below 20, indicating it is in oversold territory.

Active signals

Resistance level
$1.23
Industry
Industrial Specialties

What BBLG's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike25-18.6%16%
Bollinger Band BreakdownActive now22-12.0%18%
Bollinger Band Breakout18-18.9%11%
Any 20-session window (baseline)-13.9%27%

Computed by MarketWall from daily closing prices since July 29, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About BBLG

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine impla…

Sector
Health Care
Industry
Industrial Specialties
Employees
2

Fundamentals

1-day range
$0.385$0.409
Market cap
$1.66M
P/E (trailing)
—
P/E (forward)
-0.59
EPS (trailing)
$-1.61
Dividend yield
—
Beta
0.85
Avg. volume
379.6K
Dividend pay date
July 24, 2018
52-week range
$0.3787$2.76

Forecasts

1 analyst ratings

Buy 86%
Hold 14%
Sell 0%
1-year price forecast
High
$12.2
+2988.6%
Median
$12.2
+2988.6%
Low
$12.2
+2988.6%

Bone Biologics Corp Common Stock Competitors

Chosen by industry and closest market cap.

  • BBLG
    Bone Biologics Corp Common Stock
    $0.395
    ▲ 1.80%
    Market cap $1.66MP/E —
    $0.3787$2.76
  • COCHW
    Envoy Medical Inc Warrant
    $0.0362
    ▲ 10.03%
    Market cap $2.61MP/E —
    $0.02$0.095
  • FEED
    ENvue Medical Inc. Common Stock
    $0.371
    ▼ 24.29%
    Market cap $3.67MP/E —
    $0.2001$79.43
  • CLGN
    CollPlant Biotechnologies Ltd Ordinary Shares
    $3.63
    ▼ 1.49%
    Market cap $6.25MP/E —
    $2.64$26.8
  • HSCS
    HeartSciences Inc. Common Stock
    $3.02
    ▼ 5.03%
    Market cap $7.80MP/E —
    $1.63$5.25
  • CUPR
    Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
    $1.9
    ▼ 2.56%
    Market cap $8.98MP/E —
    $1.45$14.8
  • FGI
    FGI Industries Ltd. Ordinary Shares
    $7.49
    ▼ 0.27%
    Market cap $9.13MP/E —
    $3.14$19.93

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Institutional Ownership

March 31, 2026

Total shares held
4.4K
Total value held
$4.9K
Institutional holders
3
Top holders this quarter
  • Unknown4.1K
  • Unknown230
  • Unknown56

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.